Suicidal donor T lymphocytes halt GvHD thereby favoring the graft-versus-tumor effect in allogeneic BMT patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Thomas, E.D. et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann. Intern. Med. 104, 155–163 (1986).
Bonini, C. et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 276, 1719–1724 (1997).
Wallny, H.-J. & Rammense, H.-G. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature. 343, 275–284 (1990).
Vogelsang, G.B. & Hess, A.D. Graft-versus-host disease: New directions for a persistent problem. Blood 84, 2061–2062 (1994).
Den Haan, J.M. Identification of graft-versus-host disease associated human minor histocompatibility antigen. Science 268, 1476–1480 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pardoll, D. Taming the sinister side of BMT: Dr. Jekyll and Mr. Hyde. Nat Med 3, 833–834 (1997). https://doi.org/10.1038/nm0897-833
Issue Date:
DOI: https://doi.org/10.1038/nm0897-833